BioSpace News Archive

Business

Assembly Biosciences Provides Update on its Core Inhibitor Pipeline, Reports Fourth Quarter and Year End 2022 Financial Results and Recent Highlights

Assembly Biosciences, Inc. (Nasdaq: ASMB) today provided an update on its investigational next-generation hepatitis B virus (HBV) core inhibitors, ABI-H3733 (3733) and ABI-4334 (4334), and reported financial results and recent highlights for the fourth quarter and year ended December 31, 2022.

March 22, 2023
·
14 min read
Business

Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three and twelve months ended December 31, 2022 and provided a corporate update.

March 22, 2023
·
18 min read
Business

Aziyo Biologics Reports Record Full Year 2022 Revenues

Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”) today provided a business update and reported financial results for the fourth quarter and full year ended December 31, 2022.

March 22, 2023
·
12 min read
Business

SERA PROGNOSTICS REPORTS FOURTH QUARTER 2022 FINANCIAL RESULTS

Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced financial results for the fourth quarter and full year 2022 ended December 31, 2022.

March 22, 2023
·
9 min read
BioMidwest

CONMED Corporation Announces Annual Meeting of Stockholders - March 22, 2023

CONMED Corporation announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually.

March 22, 2023
·
2 min read
Biotech Beach

Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences - March 22, 2023

Gracell Biotechnologies Inc. announced that the management team will participate in two upcoming investor conferences.

March 22, 2023
·
1 min read
GENOMADIX ANNOUNCES FDA CLEARANCE TO MARKET THE GENOMADIX CUBE CYP2C19 SYSTEM

Genomadix, based in Ottawa, Canada, announced today the US Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of its “Genomadix CubeTM CYP2C19 System” (Cube CYP2C19 test), an automated sample-to-result PCR test.

March 22, 2023
·
2 min read
Biotech Beach

UCLA/Luskin Orthopaedic Institute for Children to Host Professional Conference and Family Forum for National Cerebral Palsy Awareness Day on March 25, 2023

Cerebral palsy is the most common childhood physical disability in the United States and throughout the world.

March 22, 2023
·
3 min read
Drug Development

Moleculin Announces Interim Phase 2 Data in STS Clinical Trial and Update on Recruiting, Preliminary Efficacy and Expected Milestones for AML Clinical Trials

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company) today announced recent activity, new positive data and expected near term milestones across its clinical development pipeline.

March 22, 2023
·
12 min read
Business

SQZ Biotechnologies Reports Full Year 2022 Financial Results and Recent Portfolio Updates

SQZ Biotechnologies Company (NYSE: SQZ), focused on unlocking the full potential of cell therapies, today reported full year 2022 financial results and recent portfolio updates.

March 22, 2023
·
7 min read